Your browser doesn't support javascript.
loading
Hepatitis C prevalence and elimination planning in Pakistan, a bottom-up approach accounting for provincial variation.
Mooneyhan, Ellen; Qureshi, Huma; Mahmood, Hassan; Tariq, Muhammad; Maqbool, Nabeel Ahmed; Anwar, Masood; Aslam, Mujahid; Azam, Farooq; Blach, Sarah; Khan, Aamir Ghafoor; Hamid, Saeed; Hussain, Tanweer; Akhter, Mohammad Khalil; Khan, Ambreen; Khan, Uzma; Khowaja, Saira; Mahmood, Khalid; Mazhar, Samra; Nawaz, Ahmad; Rose, Ayub; Ghorezai, Gul Sabeen Azam; Shah, Sabeen; Sarwar, Syeda Zahida; Razavi, Homie.
Afiliación
  • Mooneyhan E; Center for Disease Analysis Foundation (CDAF), Lafayette, Colorado, USA.
  • Qureshi H; Ministry of National Health Services, Regulations and Coordination, Islamabad, Pakistan.
  • Mahmood H; Ministry of National Health Services, Regulations and Coordination, Islamabad, Pakistan.
  • Tariq M; Chemonics International, Lahore, Pakistan.
  • Maqbool NA; Chemonics International, Lahore, Pakistan.
  • Anwar M; Chemonics International, Lahore, Pakistan.
  • Aslam M; Lady Reading Hospital, Peshawar, Pakistan.
  • Azam F; Chemonics International, Lahore, Pakistan.
  • Blach S; United States Agency for International Development (USAID), Karachi, Pakistan.
  • Khan AG; Center for Disease Analysis Foundation (CDAF), Lafayette, Colorado, USA.
  • Hamid S; Lady Reading Hospital, Peshawar, Pakistan.
  • Hussain T; Aga Khan University and Hospitals, Karachi, Pakistan.
  • Akhter MK; Chemonics International, Lahore, Pakistan.
  • Khan A; Health Department Khyber Pakhtunkhwa, Peshawar, Pakistan.
  • Khan U; Chemonics International, Lahore, Pakistan.
  • Khowaja S; Interactive Research and Development (IRD) Pakistan, Karachi, Pakistan.
  • Mahmood K; IRD Global, Singapore City, Singapore.
  • Mazhar S; Indus Hospital and Health Network, Karachi, Pakistan.
  • Nawaz A; Punjab Hepatitis Control Programme, Lahore, Pakistan.
  • Rose A; Ministry of National Health Services, Regulations and Coordination, Islamabad, Pakistan.
  • Ghorezai GSA; Lady Reading Hospital, Peshawar, Pakistan.
  • Shah S; Chemonics International, Lahore, Pakistan.
  • Sarwar SZ; United States Agency for International Development (USAID), Karachi, Pakistan.
  • Razavi H; Balochistan Hepatitis Control Programme, Quetta, Pakistan.
J Viral Hepat ; 30(4): 345-354, 2023 04.
Article en En | MEDLINE | ID: mdl-36650932
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Neoplasias Hepáticas Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hepatitis C / Neoplasias Hepáticas Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: En Revista: J Viral Hepat Asunto de la revista: GASTROENTEROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido